Clinical implication of mass-spectrometry-based selected reaction monitoring (SRM) assay in non-small cell lung cancer (NSCLC) patients exhibiting ALK gene rearrangement

An, Ho Jung ; An, Eunkyung ; Liao, Wei-Li ; Kang, Jin Hyoung ; Burrows, Jon ; Hembrough, Todd A. ; Kim, Tae-Jung

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e22145-e22145 [Periódico revisado por pares]

Texto completo disponível